三维可视化技术在中晚期肝细胞癌外科治疗中的应用价值
作者:
通讯作者:
作者单位:

1.复旦大学附属中山医院 肝肿瘤外科,上海 200032;2.复旦大学附属中山医院 放射诊断科,上海 200032;3.上海市影像医学研究所,上海 200032

作者简介:

张势域,复旦大学附属中山医院博士研究生,主要从事肝癌基础与临床方面的研究。

基金项目:

中华人民共和国科学技术部国家重点研发计划基金资助项目(2019YFC1315800;2019YFC1315802);国家自然科学基金资助项目(82150004;81830102)。


Application value of three-dimensional visualization technology in surgical treatment of intermediate and advanced hepatocellular carcinoma
Author:
Affiliation:

1.Department of Liver Surgery and Transplantation Zhongshan Hospital, Fudan University, Shanghai 200032, China;2.Department of Radiology Zhongshan Hospital, Fudan University, Shanghai 200032, China;3.Shanghai Institute of Medical Imaging, Shanghai 200032, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    背景与目的 三维(3D)可视化技术借助计算机对CT和(或)MRI的检查图像进行3D立体重建,可直观、清晰地将肝脏、胰腺、胆道、血管及肿瘤的形态和空间分布等进行展示,这对于明确肝脏脉管系统的解剖变异、准确计算残余肝体积以及手术规划具有重要的意义。本研究探讨术前肝脏3D可视化评估在中国肝癌分期(CNLC)Ⅱ~Ⅲa期患者外科治疗中的临床价值。方法 回顾性分析2015年—2017年在复旦大学附属中山医院肝肿瘤外科接受手术治疗的CNLC Ⅱ~Ⅲa期肝细胞癌(HCC)患者的临床资料。根据术前接受的评估方式,将患者分为常规影像学评估组和3D可视化评估组。采用Kaplan-Meier法比较两组患者的术后无复发生存期(RFS)和总生存期(OS),并通过单因素和多因素Cox回归分析确定影响患者预后的相关风险因素。结果 共有110例接受手术治疗的CNLC Ⅱ~Ⅲa期HCC患者被纳入研究,其中常规影像学评估组74例,3D可视化评估组36例。两组患者在性别、年龄、乙肝表面抗原、甲胎蛋白、肝功能Child-Pugh分级、肿瘤直径、肿瘤数量、大血管侵犯情况、CNLC分期、预防性介入治疗和辅助靶向治疗方面差异均无统计学意义(均P>0.05)。常规影像学评估组和3D可视化评估组的90 d病死率分别为2.8%(1/36)和4.1%(3/74),差异无统计学意义(P>0.05)。Kaplan-Meier生存分析结果显示,3D可视化评估组的OS率和RFS率均明显优于常规影像学评估组(P=0.024;P=0.014)。多因素Cox回归分析结果显示,术前3D可视化评估是OS和RFS的独立保护因素(P=0.015;P=0.010)。结论 术前3D可视化评估可显著改善中晚期HCC患者手术治疗的预后,在中晚期HCC外科治疗中具有良好的应用价值,值得进一步探索和推广。

    Abstract:

    Background and Aims Three-dimensional (3D) visualization technology utilizes computers to reconstruct 3D images from CT and/or MRI examination, which provides an intuitive and clear display of the morphology and spatial distribution of structures such as the liver, pancreas, bile ducts, blood vessels, and tumors. This technology is of great significance in clarifying anatomical variations of the liver vascular system, accurately calculating future liver reserve, and aiding in surgical planning. This study was performed to assess the clinical value of preoperative liver 3D visualization assessment in the surgical treatment of patients with China liver cancer (CNLC) stageⅡ-Ⅲa hepatocellular carcinoma (HCC).Methods The clinical data of patients with CNLC Ⅱ-Ⅲa HCC who underwent surgical treatment in the Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, between 2015 and 2017, were retrospectively analyzed. Based on their preoperative evaluation method, patients were classified into the conventional radiological and 3D visualization evaluation groups. Kaplan-Meier analysis was used to compare the two groups' postoperative recurrence-free survival (RFS) and overall survival (OS). Univariate and multivariate Cox regression analyses were performed to determine relevant risk factors affecting the prognosis of patients.Results A total of 110 patients with CNLC Ⅱ-Ⅲa HCC undergoing surgical treatment were included in the study, with 74 patients in the conventional radiological evaluation group and 36 patients in the 3D visualization evaluation group. There were no statistically significant differences between the two groups regarding sex, age, hepatitis B surface antigen, α-fetoprotein, Child-Pugh classification, tumor diameter, tumor number, macrovascular invasion, CNLC stage, prophylactic interventional therapy, and adjuvant targeted therapy (all P>0.05). The 90-d mortality rates were 2.8% (1/36) in the 3D visualization evaluation group and 4.1% (3/74) in the conventional radiological evaluation group, with no statistically significant difference (P>0.05). Kaplan-Meier survival analysis demonstrated that both OS and RFS in the 3D visualization evaluation group were significantly superior to those in the conventional radiological evaluation group (P=0.024; P=0.014). Multivariate Cox regression analysis revealed that preoperative 3D visualization assessment was an independent protective factor for OS and RFS (P=0.015; P=0.010).Conclusion Preoperative 3D visualization assessment can significantly improve the prognosis of patients with intermediate and advanced HCC undergoing surgical treatment. It has good application value in the surgical treatment of intermediate and advanced HCC and is recommended to be further explored and promoted.

    表 1 常规影像学评估组和3D可视化评估组HCC患者的基线特征[n(%)]Table 1 Baseline characteristics of HCC patients in the conventional radiological evaluation group and 3D visualization evaluation group [n (%)]
    表 2 HCC患者临床病理特征的单因素与多因素Cox回归分析Table 2 Univariate and multivariate Cox regression analysis of clinicopathologic characteristics in HCC patients
    图1 患者纳入与排除流程图Fig.1 Flowchart of patient inclusion and exclusion
    图2 HCC的3D重建示意图(自上而下依次为肝脏、肝动脉、门静脉、肝静脉和下腔静脉、肝胆胰系统以及手术规划)Fig.2 3D reconstruction illustration of HCC (from top to bottom, showing the liver, hepatic artery, portal vein, hepatic vein and inferior vena cava, hepatobiliary-pancreatic system, and surgical planning)
    图3 常规影像学评估组和3D可视化评估组HCC患者的生存曲线 A:OS曲线;B:RFS曲线Fig.3 Survival curves of HCC patients in the conventional radiological evaluation group and 3D visualization evaluation group A: OS curves; B: RFS curves
    参考文献
    相似文献
    引证文献
引用本文

张势域,成剑文,闫加艳,郭德镇,姜芝峰,杜凡,陈财忠,樊嘉,周俭,杨欣荣.三维可视化技术在中晚期肝细胞癌外科治疗中的应用价值[J].中国普通外科杂志,2023,32(7):977-985.
DOI:10.7659/j. issn.1005-6947.2023.07.002

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2023-06-03
  • 最后修改日期:2023-07-12
  • 录用日期:
  • 在线发布日期: 2023-11-03